Trial Site Detail

 

Drug:
Imatinib + Sunitinib + Regorafenib
Trial:
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Recruiting

 

University Medical Center Nijmegen st Raboud

     
Nijmegen , Gelderland 6525 GH
Netherlands

 

Principal Investigator:
 W. T. van der Graaf, MD, PhD
Contact:
 Winette.vanderGraaf@radboudumc.nl
Activation Status of this Site:
 Not yet activated
Notes about this Site:
University Medical Center Nijmegen st Raboud Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.